print logo
RSS FEED
Email the editor

Reversing Reverse Payments: The Actavis Decision


In a recent ruling, the U.S. Supreme Court put an end to so-called 'reverse settlements' in pharmaceutical patent cases. But at what cost?

(Required)
(Required)
(Required)
 
AEI